PL437608A1 - Method of determining the risk of cancer in women according to the concentration of cadmium in the blood - Google Patents

Method of determining the risk of cancer in women according to the concentration of cadmium in the blood

Info

Publication number
PL437608A1
PL437608A1 PL437608A PL43760821A PL437608A1 PL 437608 A1 PL437608 A1 PL 437608A1 PL 437608 A PL437608 A PL 437608A PL 43760821 A PL43760821 A PL 43760821A PL 437608 A1 PL437608 A1 PL 437608A1
Authority
PL
Poland
Prior art keywords
concentration
blood
cadmium
cancer
risk
Prior art date
Application number
PL437608A
Other languages
Polish (pl)
Other versions
PL243866B1 (en
Inventor
Jan LUBIŃSKI
Cezary Cybulski
Jacek Gronwald
Tomasz Huzarski
Róża Derkacz
Wojciech MARCINIAK
Anna Jakubowska
Original Assignee
Read-Gene Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Read-Gene Spółka Akcyjna filed Critical Read-Gene Spółka Akcyjna
Priority to PL437608A priority Critical patent/PL243866B1/en
Publication of PL437608A1 publication Critical patent/PL437608A1/en
Publication of PL243866B1 publication Critical patent/PL243866B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób określenia ryzyka zachorowania na raka u kobiet powyżej 50 roku życia, niepalących charakteryzujący się, tym, że obejmuje ilościową ocenę stężenia kadmu we krwi osoby badanej, przy czym stężenie wskazuje na blisko 7 krotnie zmniejszone ryzyko zachorowania na raka w stosunku do podgrupy o niższym stężeniu kadmu we krwi (< 0,28 µg/l), w przypadku występowania wartości stężenia kadmu we krwi w przedziale 0,28 - 0,33 µg/l.The subject of the report is a method of determining the risk of cancer in women over 50 years of age, non-smokers, characterized by the fact that it includes a quantitative assessment of the cadmium concentration in the blood of the tested person, the concentration indicating a nearly 7-fold reduced risk of cancer in relation to the subgroup with a lower concentration of cadmium in the blood (<0.28 µg / l), in the case of the values of cadmium concentration in the blood in the range of 0.28 - 0.33 µg / l.

PL437608A 2021-04-19 2021-04-19 Method of determining the risk of cancer in women depending on the concentration of cadmium in the blood PL243866B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL437608A PL243866B1 (en) 2021-04-19 2021-04-19 Method of determining the risk of cancer in women depending on the concentration of cadmium in the blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL437608A PL243866B1 (en) 2021-04-19 2021-04-19 Method of determining the risk of cancer in women depending on the concentration of cadmium in the blood

Publications (2)

Publication Number Publication Date
PL437608A1 true PL437608A1 (en) 2022-10-24
PL243866B1 PL243866B1 (en) 2023-10-23

Family

ID=83724541

Family Applications (1)

Application Number Title Priority Date Filing Date
PL437608A PL243866B1 (en) 2021-04-19 2021-04-19 Method of determining the risk of cancer in women depending on the concentration of cadmium in the blood

Country Status (1)

Country Link
PL (1) PL243866B1 (en)

Also Published As

Publication number Publication date
PL243866B1 (en) 2023-10-23

Similar Documents

Publication Publication Date Title
Pirola et al. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study
Hofmann et al. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Tarafder et al. Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a ‘gold standard’
Ortmann et al. Precision of estimating the time since death by vitreous potassium—Comparison of 5 different equations
Siddiqui et al. Augmentation of IL-6 production contributes to development of gestational diabetes mellitus: An Indian study
AR072258A1 (en) SET OF ELEMENTS AND METHODS TO STOP SMOKING. APPLICATIONS. AGENT. IMMUNOGENIC COMPOSITION.
Batlle et al. Metabolic acidosis or respiratory alkalosis? Evaluation of a low plasma bicarbonate using the urine anion gap
RU2016104892A (en) COMPOSITIONS AND METHODS FOR IDENTIFYING THE RISK OF DEVELOPING A CANCER DISEASE IN A SUBJECT
MY196578A (en) Method for Determining Stage of Periodontal Disease
PL437046A1 (en) Serum arsenic, zinc and selenium concentration as a marker of survival in patients with prostate cancer in Poland
PL437608A1 (en) Method of determining the risk of cancer in women according to the concentration of cadmium in the blood
Cappuccio et al. Evaluating population salt reduction programmes worldwide: the risk of cutting corners!
Bailey et al. The effect of rural-to-urban migration on renal function in an Indian population: cross-sectional data from the Hyderabad arm of the Indian Migration Study
PL437897A1 (en) Way to determine the risk of cancer in men according to the concentration of cadmium in the blood
PL438655A1 (en) Method of determining the risk of cancer in women depending on concentration of lead in the blood
da Silva et al. Two thyroid stimulating hormone assays correlated in clinical practice show disagreement in subclinical hypothyroidism patients
PL437899A1 (en) Way to determine the risk of cancer in men according to the concentration of lead in the blood
PL437571A1 (en) Method for determining the risk of cancers in women, depending on concentration of zinc in the blood
PL437898A1 (en) Way to determine the risk of cancer in men depending on the concentration of selenium in the blood
PL437895A1 (en) Way to determine the risk of cancer in men according to the concentration of copper in the blood
PL439315A1 (en) The method of determining the risk of cancer in women depending on the concentration of selenium in the blood
PL437894A1 (en) Way to determine the risk of cancer in men according to the concentration of zinc in the blood
PL438563A1 (en) Serum selenium concentration as a marker of survival in patients with malignant melanoma in Poland
PL437896A1 (en) Way to determine the risk of cancer in men according to the concentration of arsenic in the blood
PL438038A1 (en) Method of determining risk of cancer in women depending on age, history of smoking and selenium concentration in the blood